472 related articles for article (PubMed ID: 16638247)
21. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
[TBL] [Abstract][Full Text] [Related]
22. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography.
Aspromonte N; Feola M; Scardovi AB; Coletta C; D'Eri A; Giovinazzo P; Carunchio A; Chiera A; Fanelli R; Di Giacomo T; Ricci R; Ceci V; Milani L; Valle R
J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):406-13. PubMed ID: 16721202
[TBL] [Abstract][Full Text] [Related]
23. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of capillary B-type natriuretic peptide testing.
Schreinlechner M; Mrakovic A; Laschober G; Mayerl C; Griesmacher A; van Lippen L; Semjonow V; Nieuwenhuis J; van Reenen A; Mair J
Clin Chem Lab Med; 2020 Mar; 58(4):618-624. PubMed ID: 31804953
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
26. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
27. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure.
Gustafsson F; Steensgaard-Hansen F; Badskjaer J; Poulsen AH; Corell P; Hildebrandt P
J Card Fail; 2005 Jun; 11(5 Suppl):S15-20. PubMed ID: 15948095
[TBL] [Abstract][Full Text] [Related]
29. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
[TBL] [Abstract][Full Text] [Related]
30. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359
[TBL] [Abstract][Full Text] [Related]
31. [Validity and usefulness of B-type natriuretic peptide (BNP) for early detection of left ventricular dysfunction in high-risk patients in primary care].
Lobos Bejarano JM; Horrillo García C; González-González AI; Castellanos Rodríguez A; Díaz Sánchez S; Castellanos Maroto J; Rodriguez-Barrientos R; García-Fernández MA
Aten Primaria; 2012 Jan; 44(1):13-9. PubMed ID: 21636177
[TBL] [Abstract][Full Text] [Related]
32. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
Hammerer-Lercher A; Neubauer E; Müller S; Pachinger O; Puschendorf B; Mair J
Clin Chim Acta; 2001 Aug; 310(2):193-7. PubMed ID: 11498085
[TBL] [Abstract][Full Text] [Related]
33. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
[TBL] [Abstract][Full Text] [Related]
34. NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points.
Luchner A; Hengstenberg C; Löwel H; Buchner S; Schunkert H; Riegger GA; Holmer S
J Card Fail; 2005 Jun; 11(5 Suppl):S21-7. PubMed ID: 15948096
[TBL] [Abstract][Full Text] [Related]
35. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Andrijevic I; Milutinov S; Lozanov Crvenkovic Z; Matijasevic J; Andrijevic A; Kovacevic T; Bokan D; Zaric B
Lung; 2018 Oct; 196(5):583-590. PubMed ID: 29951921
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
[TBL] [Abstract][Full Text] [Related]
37. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
O'Donoghue M; Chen A; Baggish AL; Anwaruddin S; Krauser DG; Tung R; Januzzi JL
J Card Fail; 2005 Jun; 11(5 Suppl):S9-14. PubMed ID: 15948094
[TBL] [Abstract][Full Text] [Related]
38. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
39. A slightly elevated level of N-terminal pro-brain natriuretic peptide can predict coronary artery disease in a population with normal left ventricular function.
Ikeda N; Nakamura M; Yazaki Y; Ono T; Yamamoto M; Ito S; Yokouchi I; Yajima S; Iijima R; Hara H; Takagi T; Hara H; Asahara T; Sakai H; Sugi K
Heart Vessels; 2011 Sep; 26(5):473-9. PubMed ID: 21110196
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients.
Olofsson M; Boman K
Scand J Prim Health Care; 2010 Mar; 28(1):29-35. PubMed ID: 20192890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
